Kansas City, Mo. – Researchers at the Stowers Institute for Medical Research announced today a new collaboration with Google DeepMind, the Broad Institute, the University of Exeter, Memorial Sloan Kettering Cancer Center and Stanford University. Together they have released AlphaGenome Atlas, an AI‑driven, searchable database that predicts the molecular effects of more than 9 billion possible single‑letter DNA changes across the human genome.
What AlphaGenome Atlas offers
The one‑petabyte dataset provides researchers with a comprehensive catalogue of predicted variant impacts, allowing scientists to quickly prioritize which genetic changes merit laboratory study. By making these predictions accessible through a web browser, the resource eliminates the need for extensive coding skills and opens advanced genomic analysis to a broader community.
Stowers scientists’ role
Stowers Institute investigator Julia Zeitlinger, Ph.D., and bioinformatics scientist Melanie Weilert helped guide the project, linking DeepMind’s AI models to biological processes that determine cell identity. Their expertise ensured that the Atlas not only ranks variants but also reveals the regulatory motifs—short DNA sequences—that control gene activation and repression.
“Every cell type speaks a slightly different language,” Zeitlinger said. “AlphaGenome lets us query many cell types at once and discover the general rules that turn genes on and off.”
Potential impact on disease research
The Atlas includes an AlphaGenome Variant Impact (AVI) score that combines predictions from AlphaGenome, AlphaMissense and evolutionary conservation data. This single metric helps researchers rank both coding and non‑coding variants for their potential role in disease, accelerating the search for therapeutic targets.
Google DeepMind’s VP of Science and Chief Scientist, Pushmeet Kohli, Ph.D., called the resource “a powerful example of how AI can expand human knowledge and advance scientific discovery.” The team hopes the open‑access tool will speed foundational discoveries and support future treatments.
Local significance
The partnership highlights Kansas City’s growing reputation as a hub for cutting‑edge biomedical research. By collaborating with world‑leading institutions, Stowers continues to bring high‑impact science to the region and provides local researchers with tools that were previously available only to a select few.
Original reporting: KTBS 3 (Shreveport) — read the source article.
